This information was published on 2025-11-19T12:44:06 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2603566 |
| (220) |
13 Nov 2025
|
| (300) |
US, 11 Jun 2025, 99228653
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations. |
| (540) | RAYZACT |
| (550) | Word |
| (730) |
RayzeBio, Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.